89bio Inc. (ETNB) NASDAQ
$3.47 -0.15 (-4.14%)
Market Cap: $70.62M
As of 06/24/22 04:00 PM EDT. Market closed.
89bio Inc. (ETNB) NASDAQ
$3.47 -0.15 (-4.14%)
Market Cap: $70.62M
As of 06/24/22 04:00 PM EDT. Market closed.
89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe ... read more
89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is a specifically engineered glycoPEGylated analog of FGF21. BIO89-100 is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). 89bio is headquartered in San Francisco with operations in Herzliya, Israel. read less
COMPANY PROFILE
Sector
Industry
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$3.76
Previous Close
$3.62
Days Range
$3.31 - $3.84
52 week range
$2 - $22.18
Volume
1,257,854
Avg. Volume (30 days)
407,950
Market Cap
$70.62M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
20,351,384
Open
$3.76
Previous Close
$3.62
Days Range
$3.31 - $3.84
52 week range
$2 - $22.18
Volume
1,257,854
Avg. Volume (30 days)
407,950
Market Cap
$70.62M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
20,351,384
Open in:
Open in:
INSIDER TRANSACTIONS FOR 89BIO INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Mansbach Harry H | Chief Medical Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
| Martins Ryan | Chief Financial Officer | Feb 05, 2022 | Option Exercise | $5.23 | 1,022 | 5,345 | 22,478 | Apr 13, 2022, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Feb 05, 2022 | Option Exercise | $5.23 | 4,088 | 21,380 | 95,957 | Apr 13, 2022, 04:05 PM |
| Le-Nguyen Quoc | See Remarks | Feb 05, 2022 | Option Exercise | $5.23 | 1,363 | 7,128 | 31,137 | Apr 13, 2022, 04:05 PM |
| Waisbourd Ram | See Remarks | Feb 01, 2022 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 03, 2022, 04:30 PM |
| Waisbourd Ram | See Remarks | Feb 01, 2022 | Sale | $5.70 | 7,000 | 39,900 | 0 | Feb 03, 2022, 04:30 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 27, 2022 | Buy | $7.50 | 5,000 | 37,500 | 43,345 | Jan 31, 2022, 04:30 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jan 28, 2022 | Buy | $6.14 | 2,500 | 15,350 | 45,845 | Jan 31, 2022, 04:30 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jan 26, 2022 | Sale | $8.38 | 21,482 | 180,019 | 1,829,436 | Jan 27, 2022, 05:22 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Jan 25, 2022 | Sale | $8.40 | 49,091 | 412,364 | 1,840,176 | Jan 27, 2022, 05:22 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2021 | Sale | $11.48 | 7,000 | 80,360 | 0 | Dec 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Nov 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2021, 06:37 PM |
| Waisbourd Ram | See Remarks | Nov 16, 2021 | Sale | $16.49 | 7,000 | 115,430 | 0 | Nov 18, 2021, 06:37 PM |
| Waisbourd Ram | See Remarks | Oct 18, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Oct 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Oct 18, 2021 | Sale | $17.49 | 7,000 | 122,430 | 0 | Oct 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Sep 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Sep 20, 2021, 04:32 PM |
| Waisbourd Ram | See Remarks | Sep 16, 2021 | Sale | $19.46 | 7,000 | 136,220 | 0 | Sep 20, 2021, 04:32 PM |
| Waisbourd Ram | See Remarks | Aug 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Aug 18, 2021, 04:10 PM |
| Waisbourd Ram | See Remarks | Aug 16, 2021 | Sale | $18.28 | 7,000 | 127,960 | 0 | Aug 18, 2021, 04:10 PM |
| Waisbourd Ram | See Remarks | Jul 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jul 19, 2021, 04:05 PM |
| Waisbourd Ram | See Remarks | Jul 16, 2021 | Sale | $16.80 | 7,000 | 117,600 | 0 | Jul 19, 2021, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jul 07, 2021 | Buy | $17.07 | 5,000 | 85,350 | 35,000 | Jul 08, 2021, 04:05 PM |
| PALEKAR ROHAN | Chief Executive Officer | Jul 08, 2021 | Buy | $16.25 | 2,000 | 32,500 | 37,000 | Jul 08, 2021, 04:05 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jun 02, 2021 | Buy | $18.77 | 22,138 | 415,530 | 4,965,769 | Jun 04, 2021, 04:31 PM |
| Grunberg Gregory | Director | Apr 21, 2021 | Sale | $27.60 | 850 | 23,460 | 0 | Apr 23, 2021, 05:27 PM |
| Waisbourd Ram | See Remarks | Mar 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Mar 17, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Mar 16, 2021 | Sale | $24.20 | 7,000 | 169,400 | 0 | Mar 17, 2021, 04:30 PM |
| Hayden Michael R | Director | Feb 23, 2021 | Option Exercise | $2.13 | 80,904 | 172,236 | 80,904 | Feb 25, 2021, 05:01 PM |
| Waisbourd Ram | See Remarks | Feb 16, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Feb 17, 2021, 04:22 PM |
| Waisbourd Ram | See Remarks | Feb 16, 2021 | Sale | $23.39 | 7,000 | 163,730 | 0 | Feb 17, 2021, 04:22 PM |
| Waisbourd Ram | See Remarks | Jan 19, 2021 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Jan 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Jan 19, 2021 | Sale | $21.16 | 7,000 | 148,120 | 0 | Jan 20, 2021, 04:30 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Dec 18, 2020, 05:00 PM |
| Waisbourd Ram | See Remarks | Dec 16, 2020 | Sale | $27.04 | 7,000 | 189,280 | 0 | Dec 18, 2020, 05:00 PM |
| Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Option Exercise | $3.11 | 4,548 | 14,144 | 4,548 | Nov 18, 2020, 04:00 PM |
| Le-Nguyen Quoc | See Remarks | Nov 16, 2020 | Sale | $28.11 | 4,548 | 127,844 | 0 | Nov 18, 2020, 04:00 PM |
| Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Option Exercise | $1.93 | 7,000 | 13,510 | 7,000 | Nov 18, 2020, 04:00 PM |
| Waisbourd Ram | COO and Chief Business Officer | Nov 16, 2020 | Sale | $27.39 | 7,000 | 191,730 | 0 | Nov 18, 2020, 04:00 PM |
| ORBIMED ADVISORS LLC | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:09 PM |
| Naschitz Anat | Director | Sep 21, 2020 | Sale | $28.00 | 275,000 | 7,700,000 | 1,864,721 | Sep 23, 2020, 05:04 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Sep 17, 2020 | Buy | $28.00 | 1,300,000 | 36,400,000 | 4,736,214 | Sep 21, 2020, 04:30 PM |
| Longitude Capital Partners III, LLC | 10% Owner | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:11 PM |
| Grunberg Gregory | Director | Jul 10, 2020 | Buy | $27.50 | 109,090 | 2,999,975 | 2,600,877 | Jul 14, 2020, 08:08 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Jul 08, 2020 | Buy | $27.50 | 275,000 | 7,562,500 | 3,436,214 | Jul 10, 2020, 04:32 PM |
| Kariv Tomer | Director | Nov 11, 2019 | Buy | $16.00 | 250,000 | 4,000,000 | 250,000 | Nov 13, 2019, 07:10 PM |
| Naschitz Anat | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:07 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Nov 11, 2019 | Buy | $16.00 | 1,500,000 | 24,000,000 | 1,500,000 | Nov 13, 2019, 07:06 PM |
| Grunberg Gregory | Director | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:04 PM |
| Hayden Michael R | Director | Nov 11, 2019 | Buy | $16.00 | 18,750 | 300,000 | 18,750 | Nov 13, 2019, 07:02 PM |
| Longitude Capital Partners III, LLC | 10% Owner | Nov 11, 2019 | Buy | $16.00 | 575,000 | 9,200,000 | 575,000 | Nov 13, 2019, 07:02 PM |
| ORBIMED ADVISORS LLC | Director | Nov 11, 2019 | Buy | $16.00 | 837,500 | 13,400,000 | 724,363 | Nov 13, 2019, 07:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Mansbach Harry H | Chief Medical Officer | 02/05/2022 | 7,128 |
| Martins Ryan | Chief Financial Officer | 02/05/2022 | 5,345 |
| PALEKAR ROHAN | Chief Executive Officer | 02/05/2022 | 21,380 |
| Le-Nguyen Quoc | See Remarks | 02/05/2022 | 7,128 |
| Waisbourd Ram | See Remarks | 02/01/2022 | 13,510 |
| Waisbourd Ram | See Remarks | 02/01/2022 | 39,900 |
| PALEKAR ROHAN | Chief Executive Officer | 01/27/2022 | 37,500 |
| PALEKAR ROHAN | Chief Executive Officer | 01/28/2022 | 15,350 |
| ORBIMED ADVISORS LLC | 10% Owner | 01/26/2022 | 180,019 |
| ORBIMED ADVISORS LLC | 10% Owner | 01/25/2022 | 412,364 |
| Waisbourd Ram | See Remarks | 12/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 12/16/2021 | 80,360 |
| Waisbourd Ram | See Remarks | 11/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 11/16/2021 | 115,430 |
| Waisbourd Ram | See Remarks | 10/18/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 10/18/2021 | 122,430 |
| Waisbourd Ram | See Remarks | 09/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 09/16/2021 | 136,220 |
| Waisbourd Ram | See Remarks | 08/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 08/16/2021 | 127,960 |
| Waisbourd Ram | See Remarks | 07/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 07/16/2021 | 117,600 |
| PALEKAR ROHAN | Chief Executive Officer | 07/07/2021 | 85,350 |
| PALEKAR ROHAN | Chief Executive Officer | 07/08/2021 | 32,500 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 06/02/2021 | 415,530 |
| Grunberg Gregory | Director | 04/21/2021 | 23,460 |
| Waisbourd Ram | See Remarks | 03/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 03/16/2021 | 169,400 |
| Hayden Michael R | Director | 02/23/2021 | 172,236 |
| Waisbourd Ram | See Remarks | 02/16/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 02/16/2021 | 163,730 |
| Waisbourd Ram | See Remarks | 01/19/2021 | 13,510 |
| Waisbourd Ram | See Remarks | 01/19/2021 | 148,120 |
| Waisbourd Ram | See Remarks | 12/16/2020 | 13,510 |
| Waisbourd Ram | See Remarks | 12/16/2020 | 189,280 |
| Le-Nguyen Quoc | See Remarks | 11/16/2020 | 14,144 |
| Le-Nguyen Quoc | See Remarks | 11/16/2020 | 127,844 |
| Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 13,510 |
| Waisbourd Ram | COO and Chief Business Officer | 11/16/2020 | 191,730 |
| ORBIMED ADVISORS LLC | Director | 09/21/2020 | 7,700,000 |
| Naschitz Anat | Director | 09/21/2020 | 7,700,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 09/17/2020 | 36,400,000 |
| Longitude Capital Partners III, LLC | 10% Owner | 07/10/2020 | 2,999,975 |
| Grunberg Gregory | Director | 07/10/2020 | 2,999,975 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 07/08/2020 | 7,562,500 |
| Kariv Tomer | Director | 11/11/2019 | 4,000,000 |
| Naschitz Anat | Director | 11/11/2019 | 13,400,000 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 11/11/2019 | 24,000,000 |
| Grunberg Gregory | Director | 11/11/2019 | 9,200,000 |
| Hayden Michael R | Director | 11/11/2019 | 300,000 |
| Longitude Capital Partners III, LLC | 10% Owner | 11/11/2019 | 9,200,000 |
| ORBIMED ADVISORS LLC | Director | 11/11/2019 | 13,400,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2021
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2021
0.27%
1Q
06/30/2021
0.40%
2Q
03/31/2021
0.44%
3Q
12/31/2020
24.93%
4Q
09/30/2020
35.72%
5Q
06/30/2020
45.71%
6Q
03/31/2020
45.75%
7Q
Load More